pharma · Graft Rejection · Arrhythmias
Wyeth is now
Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Wyeth is now clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Wyeth is now programs — each row shows trial ID, program name, phase, status, and indication.
Wyeth is now trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Wyeth is now.
-
Etanercept , Methotrexate — Approved
Clinical update -
cyclosporine or tacrolimus — Approved
Clinical update -
SAM-315 — Phase 1
Clinical update -
DVS SR — Phase 3
Clinical update -
tigecycline — Phase 3
Clinical update -
Double-blind investigational anti-arrhythmic — Phase 2
Clinical update -
ReFacto — Approved
Clinical update -
Tigecycline — Approved
Clinical update